1. Home
  2. TMDX vs ZGN Comparison

TMDX vs ZGN Comparison

Compare TMDX & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • ZGN
  • Stock Information
  • Founded
  • TMDX 1998
  • ZGN 1910
  • Country
  • TMDX United States
  • ZGN Italy
  • Employees
  • TMDX N/A
  • ZGN N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ZGN Apparel
  • Sector
  • TMDX Health Care
  • ZGN Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • ZGN Nasdaq
  • Market Cap
  • TMDX 2.3B
  • ZGN 1.9B
  • IPO Year
  • TMDX 2019
  • ZGN N/A
  • Fundamental
  • Price
  • TMDX $88.24
  • ZGN $6.92
  • Analyst Decision
  • TMDX Buy
  • ZGN Buy
  • Analyst Count
  • TMDX 10
  • ZGN 2
  • Target Price
  • TMDX $118.44
  • ZGN $8.05
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • ZGN 1.0M
  • Earning Date
  • TMDX 04-29-2025
  • ZGN 03-27-2025
  • Dividend Yield
  • TMDX N/A
  • ZGN 1.86%
  • EPS Growth
  • TMDX N/A
  • ZGN N/A
  • EPS
  • TMDX 1.01
  • ZGN 0.31
  • Revenue
  • TMDX $441,540,000.00
  • ZGN $2,015,371,157.00
  • Revenue This Year
  • TMDX $25.33
  • ZGN $2.59
  • Revenue Next Year
  • TMDX $20.53
  • ZGN $5.41
  • P/E Ratio
  • TMDX $87.37
  • ZGN $22.28
  • Revenue Growth
  • TMDX 82.74
  • ZGN 2.21
  • 52 Week Low
  • TMDX $55.00
  • ZGN $6.05
  • 52 Week High
  • TMDX $177.37
  • ZGN $13.36
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 70.61
  • ZGN 45.34
  • Support Level
  • TMDX $82.62
  • ZGN $6.43
  • Resistance Level
  • TMDX $88.48
  • ZGN $7.15
  • Average True Range (ATR)
  • TMDX 5.48
  • ZGN 0.47
  • MACD
  • TMDX 1.98
  • ZGN 0.05
  • Stochastic Oscillator
  • TMDX 99.09
  • ZGN 53.11

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About ZGN Ermenegildo Zegna N.V.

Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.

Share on Social Networks: